United States
INTENT
ClinicalTrials.gov # NCT07543367 (opens in new tab)
Eligibility: Severe bilateral upper limb motor weakness due to ALS.
Register interest (opens in new tab)→Join our trial
We have two active clinical studies investigating the use of our Stentrode device to restore motor control over digital devices. The study involves having a device placed via a procedure using a catheter inserted through the jugular vein. The trial then assesses how you can use the device to control Apple devices to improve your ability to engage with the digital world.
Register your interest to learn about new sites opening near you.
As I can no longer move my hands, I can ask my wife to feed me, bring me water, help me dress, move my pillows and other activities. It's a great relief to know that, if my voice goes, I will be able to text her my needs, and can continue to tell her how much I love and appreciate her.
Australia
FOCUS
ClinicalTrials.gov # NCT07533903 (opens in new tab)
Eligibility: Severe bilateral upper limb motor weakness due to a range of motor impairment conditions.
Register interest (opens in new tab)→- Mount Sinai Hospital
New York, NY - University at Buffalo Neurosurgery
Buffalo, NY - UT Southwestern Medical Center
Dallas, TX - Mayo Clinic
Jacksonville, FL
Pending
- UPMC PresbyterianPittsburgh, PA
- Royal Melbourne Hospital
Melbourne, VIC - Liverpool Hospital
Sydney, NSW
Pending
- The Alfred HospitalMelbourne, VIC
- Royal Brisbane and Women's HospitalBrisbane, QLD
Patients with tetraplegia face unique and important health challenges due to the loss of autonomy that can occur with motor impairment. Implantable MNP BCI's hold promise to restore continuous autonomy through the restoration of motor intent transmission to control the digital environment.